{
    "paper_id": "PMC7192402",
    "metadata": {
        "title": "Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis such as the COVID-19 pandemic",
        "authors": [
            {
                "first": "Covadonga",
                "middle": [],
                "last": "Mart\u00ed",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jos\u00e9",
                "middle": [
                    "I"
                ],
                "last": "S\u00e1nchez-M\u00e9ndez",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "In conclusion, in critical situations due to the pandemic, NET offers a safe and effective option for patients with luminal-like breast cancers and enables them to temporarily avoid surgery and visits to clinics.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "The authors declare that they have no conflicts of interest.",
            "cite_spans": [],
            "section": "Conflicts of interest",
            "ref_spans": []
        },
        {
            "text": "The authors have received no funds for the development of this work.",
            "cite_spans": [],
            "section": "Funding statement",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Spring",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "KL",
                    "middle": [],
                    "last": "Reynolds",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "JAMA Oncol",
            "volume": "2",
            "issn": "11",
            "pages": "1477-1486",
            "other_ids": {
                "DOI": [
                    "10.1001/jamaoncol.2016.1897"
                ]
            }
        },
        "BIBREF1": {
            "title": "Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Ellis",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Natl Cancer Inst",
            "volume": "100",
            "issn": "19",
            "pages": "1380-1388",
            "other_ids": {
                "DOI": [
                    "10.1093/jnci/djn309"
                ]
            }
        },
        "BIBREF2": {
            "title": "Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Goto-Yamaguchi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yamamoto-Ibusuki",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yamamoto",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Breast Cancer Res Treat",
            "volume": "172",
            "issn": "2",
            "pages": "353-362",
            "other_ids": {
                "DOI": [
                    "10.1007/s10549-018-4933-5"
                ]
            }
        },
        "BIBREF3": {
            "title": "Molecular response to aromatase inhibitor treatment in primary breast cancer",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Mackay",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Urruticoechea",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Michael",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Breast Cancer Res",
            "volume": "9",
            "issn": "3",
            "pages": "1-14",
            "other_ids": {
                "DOI": [
                    "10.1186/bcr1732"
                ]
            }
        },
        "BIBREF4": {
            "title": "Lessons in precision oncology from neoadjuvant endocrine therapy trials in ER+ breast cancer",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Ellis",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Breast",
            "volume": "34",
            "issn": "",
            "pages": "S104-S107",
            "other_ids": {
                "DOI": [
                    "10.1016/j.breast.2017.06.039"
                ]
            }
        },
        "BIBREF5": {
            "title": "Ki\u201167 index value and progesterone receptor status can predict prognosis and suitable treatment in node\u2011negative breast cancer patients with estrogen receptor\u2011positive and HER2\u2011negative tumors",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Arima",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Nishimura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Osako",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Oncol Lett",
            "volume": "17",
            "issn": "1",
            "pages": "616-622",
            "other_ids": {
                "DOI": [
                    "10.3892/ol.2018.9633"
                ]
            }
        },
        "BIBREF6": {
            "title": "Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: results from the American college of surgeons oncology group Z1031 trial (alliance)",
            "authors": [
                {
                    "first": "MJ",
                    "middle": [],
                    "last": "Ellis",
                    "suffix": ""
                },
                {
                    "first": "VJ",
                    "middle": [],
                    "last": "Suman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hoog",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Clin Oncol",
            "volume": "35",
            "issn": "10",
            "pages": "1061-1069",
            "other_ids": {
                "DOI": [
                    "10.1200/JCO.2016.69.4406"
                ]
            }
        },
        "BIBREF7": {
            "title": "Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Goncalves",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "DeSchryver",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Breast Cancer Res Treat",
            "volume": "165",
            "issn": "2",
            "pages": "355-364",
            "other_ids": {
                "DOI": [
                    "10.1007/s10549-017-4329-y"
                ]
            }
        },
        "BIBREF8": {
            "title": "Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Iwamoto",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Katagiri",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Niikura",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Oncotarget",
            "volume": "8",
            "issn": "16",
            "pages": "26122-26128",
            "other_ids": {
                "DOI": [
                    "10.18632/oncotarget.15385"
                ]
            }
        },
        "BIBREF9": {
            "title": "Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Selli",
                    "suffix": ""
                },
                {
                    "first": "JM",
                    "middle": [],
                    "last": "Dixon",
                    "suffix": ""
                },
                {
                    "first": "AH",
                    "middle": [],
                    "last": "Sims",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Breast Cancer Res",
            "volume": "18",
            "issn": "1",
            "pages": "1-10",
            "other_ids": {
                "DOI": [
                    "10.1186/s13058-016-0779-0"
                ]
            }
        },
        "BIBREF10": {
            "title": "The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study",
            "authors": [
                {
                    "first": "RS",
                    "middle": [],
                    "last": "Finn",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Crown",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Lang",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Lancet Oncol",
            "volume": "16",
            "issn": "1",
            "pages": "25-35",
            "other_ids": {
                "DOI": [
                    "10.1016/S1470-2045(14)71159-3"
                ]
            }
        },
        "BIBREF11": {
            "title": "Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Abe",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Abe",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Enomoto",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Lancet",
            "volume": "378",
            "issn": "9793",
            "pages": "771-784",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(11)60993-8"
                ]
            }
        },
        "BIBREF12": {
            "title": "Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Cottu",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "D\u2019Hondt",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Dureau",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Ann Oncol",
            "volume": "",
            "issn": "October",
            "pages": "1-7",
            "other_ids": {
                "DOI": [
                    "10.1093/annonc/mdy448"
                ]
            }
        },
        "BIBREF13": {
            "title": "Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Baselga",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Semiglazov",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Van Dam",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Clin Oncol",
            "volume": "27",
            "issn": "16",
            "pages": "2630-2637",
            "other_ids": {
                "DOI": [
                    "10.1200/JCO.2008.18.8391"
                ]
            }
        },
        "BIBREF14": {
            "title": "Personalizing the treatment of women with early breast cancer: highlights of the st gallen international expert consensus on the primary therapy of early breast Cancer 2013",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Goldhirsch",
                    "suffix": ""
                },
                {
                    "first": "EP",
                    "middle": [],
                    "last": "Winer",
                    "suffix": ""
                },
                {
                    "first": "AS",
                    "middle": [],
                    "last": "Coates",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Ann Oncol",
            "volume": "24",
            "issn": "9",
            "pages": "2206-2223",
            "other_ids": {
                "DOI": [
                    "10.1093/annonc/mdt303"
                ]
            }
        },
        "BIBREF15": {
            "title": "Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Masuda",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Sagara",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kinoshita",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Lancet Oncol",
            "volume": "13",
            "issn": "4",
            "pages": "345-352",
            "other_ids": {
                "DOI": [
                    "10.1016/S1470-2045(11)70373-4"
                ]
            }
        },
        "BIBREF16": {
            "title": "Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor\u2014positive, human epidermal growth factor receptor 2\u2014negative early breast cancer: TEXT and SOFT trials",
            "authors": [
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Regan",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Francis",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Pagani",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "J Clin Oncol",
            "volume": "34",
            "issn": "19",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1200/JCO.2015.64.3171"
                ]
            }
        },
        "BIBREF17": {
            "title": "ESMO management and treatment adapted recommendations in the COVID-19 era: breast cancer",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "",
            "authors": [],
            "year": 2020,
            "venue": "Recommendations for Prioritization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic: Executive Summary",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bradley",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Burrett",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Clarke",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Lancet",
            "volume": "386",
            "issn": "10001",
            "pages": "1341-1352",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(15)61074-1"
                ]
            }
        },
        "BIBREF20": {
            "title": "Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer",
            "authors": [
                {
                    "first": "VF",
                    "middle": [],
                    "last": "Semiglazov",
                    "suffix": ""
                },
                {
                    "first": "VV",
                    "middle": [],
                    "last": "Semiglazov",
                    "suffix": ""
                },
                {
                    "first": "GA",
                    "middle": [],
                    "last": "Dashyan",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Cancer",
            "volume": "110",
            "issn": "2",
            "pages": "244-254",
            "other_ids": {
                "DOI": [
                    "10.1002/cncr.22789"
                ]
            }
        },
        "BIBREF21": {
            "title": "NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Palmieri",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cleator",
                    "suffix": ""
                },
                {
                    "first": "LS",
                    "middle": [],
                    "last": "Kilburn",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Breast Cancer Res Treat",
            "volume": "148",
            "issn": "3",
            "pages": "581-590",
            "other_ids": {
                "DOI": [
                    "10.1007/s10549-014-3183-4"
                ]
            }
        },
        "BIBREF22": {
            "title": "Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Alba",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Calvo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Albanell",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Ann Oncol",
            "volume": "23",
            "issn": "12",
            "pages": "3069-3074",
            "other_ids": {
                "DOI": [
                    "10.1093/annonc/mds132"
                ]
            }
        },
        "BIBREF23": {
            "title": "Pre-operative endocrine therapy",
            "authors": [
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Arthur",
                    "suffix": ""
                },
                {
                    "first": "AK",
                    "middle": [],
                    "last": "Turnbull",
                    "suffix": ""
                },
                {
                    "first": "LR",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Curr Breast Cancer Rep",
            "volume": "9",
            "issn": "4",
            "pages": "202-209",
            "other_ids": {
                "DOI": [
                    "10.1007/s12609-017-0255-6"
                ]
            }
        },
        "BIBREF24": {
            "title": "Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Cain",
                    "suffix": ""
                },
                {
                    "first": "IR",
                    "middle": [],
                    "last": "Macpherson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Beresford",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Clin Oncol",
            "volume": "29",
            "issn": "10",
            "pages": "642-652",
            "other_ids": {
                "DOI": [
                    "10.1016/j.clon.2017.06.003"
                ]
            }
        },
        "BIBREF25": {
            "title": "Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: a multicenter, open-label, phase II study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Sato",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Masuda",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Morimoto",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Cancer Med",
            "volume": "7",
            "issn": "7",
            "pages": "3044-3056",
            "other_ids": {
                "DOI": [
                    "10.1002/cam4.1600"
                ]
            }
        }
    }
}